Who are amoxicillin and gentamicin's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): procaine penicillin, gentamicin, amoxicillin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/amoxicillin-and-gentamicin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

amoxicillin and gentamicin — Competitive Intelligence Brief

amoxicillin and gentamicin (amoxicillin and gentamicin) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Beta-lactam antibiotic, Aminoglycoside antibiotic. Area: Infectious diseases.

phase 3 Beta-lactam antibiotic, Aminoglycoside antibiotic Penicillin-binding proteins, 30S ribosomal subunit Infectious diseases Small molecule Live · refreshed every 30 min

Target snapshot

amoxicillin and gentamicin (amoxicillin and gentamicin) — Aga Khan University. Amoxicillin is a beta-lactam antibiotic that inhibits cell wall synthesis in bacteria, while gentamicin is an aminoglycoside antibiotic that interferes with bacterial protein synthesis.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
amoxicillin and gentamicin TARGET	amoxicillin and gentamicin	Aga Khan University	phase 3	Beta-lactam antibiotic, Aminoglycoside antibiotic	Penicillin-binding proteins, 30S ribosomal subunit
procaine penicillin, gentamicin, amoxicillin	procaine penicillin, gentamicin, amoxicillin	Aga Khan University	phase 3	Combination antibiotic	Penicillin-binding proteins, 30S ribosomal subunit

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Beta-lactam antibiotic, Aminoglycoside antibiotic class)

Aga Khan University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). amoxicillin and gentamicin — Competitive Intelligence Brief. https://druglandscape.com/ci/amoxicillin-and-gentamicin. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab